One woman, two stories…

July 5, 2016
by Stephanie Chisolm

Writer and BCAN volunteer patient advocate Renata Khoshroo Louwers shares her personal perspective after her first husband Ahmad was diagnosed with Stage IV bladder cancer.

Read More...

BCAN Announces 2016 Young Investigator Awardees

June 22, 2016
by Stephanie Chisolm

The Bladder Cancer Advocacy Network (BCAN) has announced the recipients of the 2016 Young Investigator Awards. The Young Investigator Awards fund researchers in basic, translational, clinical, epidemiologic, bio-engineering or any other scientific or research field. Recipients must be working in a research environment capable of supporting transformational bladder cancer research. The Stephen Hale Gushée Young Investigator Award will support Kent William Mouw, M.D., Ph.D. of Dana-Farber Cancer Institute, for his research “Identifying Genomic Determinants of Chemoradiotherapy Response in Muscle-Invasive Bladder Cancer.” Dr. Mouw’s study will leverage new genomic techniques to better understand how these biomarkers can benefit muscle invasive bladder cancer…

Read More...

Press Release: FDA Approves New Bladder Cancer Treatment

May 18, 2016
by Andrea Maddox-Smith

The Bladder Cancer Advocacy Network (BCAN) applauds the U.S. Food and Drug Administration (FDA) approval of an innovative, first-of-its-kind bladder cancer treatment, establishing a brand new class of therapy for the disease. Genentech, a member of the Roche Group, produced this new treatment, TECENTRIQ™ (atezolizumab), which allows the body’s immune system to work more effectively to fight cancer.

Read More...